Both murine models of obesity and patients with obesity and type 2 diabetes have reduced levels of hepatic AQP9 accompanied by a decrease in liver glycerol permeability [57,58]. The gene discussed is AQP9; the disease is obesity due to melanocortin 4 receptor deficiency.